EDA-mediated TLR4 signaling is thought to contribute to adverse inflammation following cardiac infarction [71], cerebral ischemia [72], allergen challenge [73], graft vs. host disease [74], and pre-term birth [75]. This evidence concerns the gene TLR4 and Cerebral ischemia.